Wellgistics Health Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Net Income	-39.2	-6.86	-2.9	-0.02
Depreciation & Amortization	1.94	1.11	-	-
Stock-Based Compensation	28.85	1.08	-	-
Provision & Write-off of Bad Debts	0.17	0.09	-	-
Change in Accounts Receivable	-0.22	-0.04	-	-
Change in Inventory	-0.29	-0.07	-	-
Change in Accounts Payable	0.91	-0.88	1.03	0.02
Change in Other Net Operating Assets	5.23	4.34	1.51	-
Operating Cash Flow	-2.6	-1.22	-0.35	-
Cash Acquisitions	0.93	0.93	-	-
Sale (Purchase) of Intangibles	-0.65	-0.38	-	-
Other Investing Activities	-0.09	-0.09	-	-
Investing Cash Flow	0.2	0.47	-	-
Short-Term Debt Issued	-	0.76	-	-
Long-Term Debt Issued	-	1.31	0.35	-
Total Debt Issued	2.91	2.07	0.35	-
Short-Term Debt Repaid	-	-0.14	-	-
Total Debt Repaid	-0.51	-0.14	-	-
Net Debt Issued (Repaid)	2.39	1.94	0.35	-
Issuance of Common Stock	4	0.01	0	-
Other Financing Activities	-1.76	-0.16	-	-
Financing Cash Flow	4.63	1.78	0.35	-
Net Cash Flow	2.22	1.03	0	-
Cash Interest Paid	0.95	0.33	-	-
Levered Free Cash Flow	18.23	6.37	-	-
Unlevered Free Cash Flow	19.43	6.89	-	-
Change in Working Capital	5.64	3.34	2.55	0.02

Updated Dec 18, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q